Xencor
XNCR
#5580
Rank
โ‚ฌ1.06 B
Marketcap
14,86ย โ‚ฌ
Share price
-4.63%
Change (1 day)
-37.88%
Change (1 year)

Earnings for Xencor (XNCR)

Earnings in 2025 (TTM): -โ‚ฌ0.13 Billion

According to Xencor's latest financial reports the company's current earnings are โ‚ฌ0.16 Billion. In 2024 the company made an earning of -โ‚ฌ0.21 Billion a decrease over its 2023 earnings that were of -โ‚ฌ0.11 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Xencor from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.13 Billion-39.29%
2024 -โ‚ฌ0.21 Billion101.73%
2023 -โ‚ฌ0.11 Billion120.95%
2022 -โ‚ฌ46.82 Million-165.97%
2021 โ‚ฌ70.97 M-219.18%
2020 -โ‚ฌ59.56 Million-355.02%
2019 โ‚ฌ23.35 M-138.61%
2018 -โ‚ฌ60.48 Million21.07%
2017 -โ‚ฌ49.96 Million-336.25%
2016 โ‚ฌ21.14 M-239.93%
2015 -โ‚ฌ15.11 Million7.12%
2014 -โ‚ฌ14.11 Million-72.75%
2013 -โ‚ฌ51.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Seagen
SGEN
-โ‚ฌ0.68 Billion 472.91%๐Ÿ‡บ๐Ÿ‡ธ USA
MacroGenics
MGNX
-โ‚ฌ64.28 Million-45.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.08 B-6,074.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.83 B-16,832.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.82 B-23,576.55%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ1.42 B-1,302.96%๐Ÿ‡บ๐Ÿ‡ธ USA